Target intelligence / Profile preview

SARS-CoV-2 membrane protein (M protein) (M protein)

Target
M protein
Molecular classification
Structural protein, Viral membrane protein, Transmembrane protein
01

Overview

The SARS-CoV-2 membrane (M) protein is a critical structural component that serves as a scaffold for viral assembly and budding. As the most abundant protein in the viral envelope, M mediates interactions with spike (S), envelope (E), and nucleocapsid (N) proteins, organizing their localization to sites of viral assembly. The M protein contains multiple T cell epitope regions that are recognized by CD4+ and CD8+ T cells following natural infection or vaccination. While specific M protein-derived epitopes (such as nucleocapsid protein cross-reactive regions) can generate robust T cell responses, the M protein itself is not a direct pharmaceutical drug target. Rather, M protein epitopes are of significant interest for rational vaccine design, as they represent conserved immunodominant regions less susceptible to viral mutations compared to spike protein epitopes, potentially providing durable cross-protection against SARS-CoV-2 variants.

Other names
Membrane glycoproteinE1 membrane glycoproteinMatrix protein
02

Mechanism of action

N/A for epitopes (they are vaccine immunogens, not drug targets)

03

Biological functions

Viral assembly and buddingStructural organization of virionsInteraction with other viral structural proteins (spike, envelope, nucleocapsid)Immune evasion
04

Disease associations

Infection (COVID-19)
05

Safety considerations

Not applicable; epitopes are not drug targets. M protein as a vaccine component is generally well-tolerated.
06

Interacting drugs

None directly target M protein; vaccines incorporating M protein epitopes are in development
07

Biomarkers

M protein-specific CD8+ and CD4+ T cell responses can serve as markers of vaccine-induced immunity or natural infection

Beyond the preview

Go deeper on SARS-CoV-2 membrane protein (M protein) (M protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SARS-CoV-2 membrane protein (M protein) (M protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call